Ifp Advisors, Inc Veracyte, Inc. Transaction History

Ifp Advisors, Inc

$2.42 Billion
Q2 2024

A detailed history of Ifp Advisors, Inc transactions in Veracyte, Inc. stock. As of the latest transaction made, Ifp Advisors, Inc holds 2,093 shares of VCYT stock, worth $85,792. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,093

Previous 2,116 1.09%

Holding current value

$85,792

Previous $46,000 2.17%

% of portfolio

0.0%

Previous 0.0%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 30, 2024	SELL	$18.86 - $23.55 $433 - $541	-23 Reduced 1.09%	2,093 $45,000
Q1 2024 Jul 30, 2024	SELL	$21.0 - $29.1 $420 - $582	-20 Reduced 0.94%	2,116 $46,000
Q4 2023 Jan 09, 2024	BUY	$19.72 - $28.68 $59 - $86	3 Added 0.14%	2,136 $58,000
Q3 2023 Oct 12, 2023	SELL	$22.33 - $29.92 $334 - $448	-15 Reduced 0.7%	2,133 $47,000
Q2 2023 Aug 04, 2023	SELL	$20.96 - $26.99 $524 - $674	-25 Reduced 1.15%	2,148 $54,000
Q1 2023 Apr 18, 2023	SELL	$20.58 - $27.89 $5,289 - $7,167	-257 Reduced 10.58%	2,173 $48,000
Q3 2022 Nov 08, 2022	BUY	$16.58 - $27.9 $547 - $920	33 Added 1.38%	2,430 $38,000
Q2 2022 Sep 06, 2022	BUY	$15.45 - $29.52 $37,033 - $70,759	2,397 New	2,397 $37,000
Q2 2022 Aug 12, 2022	SELL	$15.45 - $29.52 $37,033 - $70,759	-2,397 Closed	0 $0
Q1 2022 Sep 06, 2022	BUY	$21.94 - $42.51 $10,289 - $19,937	469 Added 24.33%	2,397 $66,000
Q1 2022 Aug 08, 2022	BUY	$21.94 - $42.51 $460 - $892	21 Added 1.1%	1,928 $53,000
Q4 2021 Jan 12, 2022	BUY	$36.09 - $53.79 $288 - $430	8 Added 0.42%	1,907 $79,000
Q3 2021 Oct 06, 2021	SELL	$35.62 - $52.97 $2,635 - $3,919	-74 Reduced 3.75%	1,899 $88,000
Q2 2021 Jul 13, 2021	SELL	$32.94 - $56.62 $197 - $339	-6 Reduced 0.3%	1,973 $82,000
Q1 2021 Apr 30, 2021	BUY	$44.47 - $81.38 $14,363 - $26,285	323 Added 19.5%	1,979 $107,000
Q4 2020 Jan 25, 2021	BUY	$32.49 - $61.88 $682 - $1,299	21 Added 1.28%	1,656 $80,000
Q3 2020 Oct 29, 2020	BUY	$26.73 - $35.67 $641 - $856	24 Added 1.49%	1,635 $53,000
Q2 2020 Aug 05, 2020	SELL	$19.49 - $28.11 $487 - $702	-25 Reduced 1.53%	1,611 $39,000
Q1 2020 May 12, 2020	BUY	$16.13 - $30.17 $1,354 - $2,534	84 Added 5.41%	1,636 $40,000
Q4 2019 Jan 17, 2020	SELL	$20.78 - $29.99 $561 - $809	-27 Reduced 1.71%	1,552 $45,000
Q3 2019 Nov 07, 2019	BUY	$23.87 - $30.93 $37,690 - $48,838	1,579 New	1,579 $39,000
Q2 2018 Aug 07, 2018	SELL	$5.39 - $9.66 $1,078 - $1,932	-200 Closed	0 $0
Q1 2018 Jun 03, 2019	BUY	$5.44 - $6.97 $1,088 - $1,394	200 New	200 $1,000
Q1 2018 May 09, 2018	SELL	$5.44 - $6.97 $1,088 - $1,394	-200 Closed	0 $0
Q3 2017 Oct 30, 2017	SELL	$7.81 - $8.77 $4,686 - $5,262	-600 Reduced 75.0%	200 $2,000
Q2 2017 Jun 03, 2019	BUY	N/A	800	800 $7,000

Others Institutions Holding VCYT

# of Institutions

307

Shares Held

81.7M

Call Options Held

134K

Put Options Held

13.3K

View Full List

About VERACYTE, INC.

Ticker VCYT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,575,904
Market Cap $2.93B
Description
Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...

More about VCYT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ifp Advisors, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ifp Advisors, Inc with notifications on news.

Account